Cutler Group’s VanEck Biotech ETF BBH Stock Holding History

Cutler Group’s Portfolio BBH Stock Details BBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-400	Closed	-$4K	–	5674
2021 Q1	$4K	Buy	+400	New	+$72.3K	﹤0.01%	4470
2020 Q3	–	Sell	-1,200	Closed	-$11K	–	4659
2020 Q2	$11K	Buy	+1,200	New	+$182K	﹤0.01%	2793
2018 Q1	–	Sell	-500	Closed	-$1K	–	4439
2017 Q4	$1K	Hold	500	–	–	﹤0.01%	4367
2017 Q3	$1K	Buy	+500	New	+$65.1K	﹤0.01%	5336
2017 Q2	–	Sell	-15,400	Closed	-$72K	–	6337
2017 Q1	$72K	Buy	15,400 +13,300	+633%	+$1.56M	﹤0.01%	2047
2016 Q4	$2K	Sell	2,100 -3,000	-59%	-$326K	﹤0.01%	5547
2016 Q3	$6K	Sell	5,100 -4,600	-47%	-$524K	﹤0.01%	4720
2016 Q2	$45K	Buy	9,700 +9,300	+2,325%	+$992K	﹤0.01%	2457
2016 Q1	$4K	Sell	400 -100	-20%	-$10.4K	﹤0.01%	5000
2015 Q4	$1K	Buy	+500	New	+$61.3K	﹤0.01%	5839

Other funds holding BBH

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

MIM

Miller Investment Management West Conshohocken, Pennsylvania $1.01B AUM 13.96% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

CIG

Consolidated Investment Group Englewood, Colorado $922M AUM 28.87% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Cutler Group's BBH Position: Q4 2023 in Review

Cutler Group sold out of VanEck Biotech ETF (BBH) in Q4 2023, closing a stake of 115 shares — an estimated $17.7K sold.

Cutler Group first reported a position in BBH in Q1 2016 and held it in 20 quarters. The position peaked at $486K in Q2 2016. 116 funds tracked by Wall St. Rank hold BBH as of Q4 2023.

Cutler Group reported no remaining VanEck Biotech ETF position as of Q4 2023 after selling out during the quarter.
Cutler Group sold 115 VanEck Biotech ETF shares in Q4 2023, an estimated $17.7K.
Cutler Group first reported a position in VanEck Biotech ETF in Q1 2016 and held it in 20 quarters.
Cutler Group's VanEck Biotech ETF position peaked at $486K in Q2 2016.
116 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q4 2023.

Based on Cutler Group's 13F filing for Q4 2023, filed 18 Jan 2024.